
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18647882
[patent_doc_number] => 20230293659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/006627
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006627 | TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF | Jul 29, 2021 | Abandoned |
Array
(
[id] => 18647882
[patent_doc_number] => 20230293659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/006627
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006627 | TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF | Jul 29, 2021 | Abandoned |
Array
(
[id] => 18511682
[patent_doc_number] => 20230227864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACETYL-COA DERIVED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/006506
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006506
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006506 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACETYL-COA DERIVED PRODUCTS | Jul 22, 2021 | Pending |
Array
(
[id] => 17814316
[patent_doc_number] => 11419904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Immunomodulatory compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/372614
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 55708
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372614 | Immunomodulatory compositions and methods of use thereof | Jul 11, 2021 | Issued |
Array
(
[id] => 18597259
[patent_doc_number] => 20230272054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 18/014980
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014980 | COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS | Jul 5, 2021 | Pending |
Array
(
[id] => 17200133
[patent_doc_number] => 20210340228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/368566
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368566 | METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS | Jul 5, 2021 | Abandoned |
Array
(
[id] => 17441898
[patent_doc_number] => 20220062403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED
[patent_app_type] => utility
[patent_app_number] => 17/367193
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367193 | ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED | Jul 1, 2021 | Pending |
Array
(
[id] => 17441898
[patent_doc_number] => 20220062403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED
[patent_app_type] => utility
[patent_app_number] => 17/367193
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367193 | ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED | Jul 1, 2021 | Pending |
Array
(
[id] => 18565709
[patent_doc_number] => 20230256036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SERPIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/003001
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003001 | SERPIN PRODUCTION | Jun 24, 2021 | Abandoned |
Array
(
[id] => 18565709
[patent_doc_number] => 20230256036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SERPIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/003001
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003001 | SERPIN PRODUCTION | Jun 24, 2021 | Abandoned |
Array
(
[id] => 18582874
[patent_doc_number] => 20230265131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => AMUC-1100 POLYPEPTIDE VARIANTS FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS
[patent_app_type] => utility
[patent_app_number] => 18/003974
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003974
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003974 | AMUC-1100 POLYPEPTIDE VARIANTS FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS | Jun 20, 2021 | Pending |
Array
(
[id] => 18522234
[patent_doc_number] => 20230232882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals
[patent_app_type] => utility
[patent_app_number] => 17/999668
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999668 | Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals | Jun 2, 2021 | Pending |
Array
(
[id] => 18693983
[patent_doc_number] => 20230324386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Novel Coronavirus Testing
[patent_app_type] => utility
[patent_app_number] => 18/007764
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007764 | Novel Coronavirus Testing | Jun 1, 2021 | Pending |
Array
(
[id] => 18693983
[patent_doc_number] => 20230324386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Novel Coronavirus Testing
[patent_app_type] => utility
[patent_app_number] => 18/007764
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007764 | Novel Coronavirus Testing | Jun 1, 2021 | Pending |
Array
(
[id] => 18693983
[patent_doc_number] => 20230324386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Novel Coronavirus Testing
[patent_app_type] => utility
[patent_app_number] => 18/007764
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007764 | Novel Coronavirus Testing | Jun 1, 2021 | Pending |
Array
(
[id] => 18420535
[patent_doc_number] => 20230174997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Method for Preparing Plasmid Containing Type I Polyketide Synthase Gene
[patent_app_type] => utility
[patent_app_number] => 17/926204
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926204 | Method for Preparing Plasmid Containing Type I Polyketide Synthase Gene | May 24, 2021 | Pending |
Array
(
[id] => 17080678
[patent_doc_number] => 20210275684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => HIGH-AFFINITY ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/327845
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327845 | HIGH-AFFINITY ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE | May 23, 2021 | Abandoned |
Array
(
[id] => 17242015
[patent_doc_number] => 20210361758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => STREPTOCOCCAL VACCINES AND METHODS FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/327515
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327515 | STREPTOCOCCAL VACCINES AND METHODS FOR USE | May 20, 2021 | Abandoned |
Array
(
[id] => 17242015
[patent_doc_number] => 20210361758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => STREPTOCOCCAL VACCINES AND METHODS FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/327515
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327515 | STREPTOCOCCAL VACCINES AND METHODS FOR USE | May 20, 2021 | Abandoned |
Array
(
[id] => 19332796
[patent_doc_number] => 20240247226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => METHOD OF CULTURING ALGAE
[patent_app_type] => utility
[patent_app_number] => 17/918666
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918666 | METHOD OF CULTURING ALGAE | May 9, 2021 | Pending |